OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 129 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $102,000 | -67.2% | 181,083 | 0.0% | 0.00% | – |
| Q4 2015 | $311,000 | -18.6% | 181,083 | 0.0% | 0.00% | – |
| Q3 2015 | $382,000 | -57.4% | 181,083 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $896,000 | -36.8% | 181,083 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,418,000 | +29.3% | 181,083 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,097,000 | +59.0% | 181,083 | +11.9% | 0.00% | 0.0% |
| Q3 2014 | $690,000 | -31.0% | 161,883 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,000,000 | +14.9% | 161,883 | +21.0% | 0.00% | 0.0% |
| Q1 2014 | $870,000 | +15.4% | 133,783 | -0.0% | 0.00% | 0.0% |
| Q4 2013 | $754,000 | -8.3% | 133,838 | +0.0% | 0.00% | 0.0% |
| Q3 2013 | $822,000 | +4.6% | 133,821 | -0.4% | 0.00% | 0.0% |
| Q2 2013 | $786,000 | – | 134,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,235,000 | $5,261,000 | 5.04% |
| Cheyne Capital Management (UK) LLP | 693,642 | $2,958,000 | 1.05% |
| Rock Springs Capital Management LP | 1,250,000 | $5,325,000 | 0.82% |
| NEA Management Company, LLC | 3,709,000 | $15,800,000 | 0.80% |
| Rhenman & Partners Asset Management AB | 494,000 | $2,104,000 | 0.62% |
| Palo Alto Investors LP | 1,931,324 | $8,227,000 | 0.62% |
| PFM Health Sciences, LP | 4,838,324 | $20,611,000 | 0.47% |
| CQS Cayman LP | 1,750,000 | $7,455,000 | 0.44% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,700,371 | $7,243,000 | 0.37% |
| SAMLYN CAPITAL, LLC | 2,299,000 | $9,794,000 | 0.20% |